|
[1] Schleicher E, Gerdes C, Petersmann A, et al.Definition, classification and diagnosis of diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2022, 127, S1-S7. [2] Zheng Y, Ley S H, Hu F B.Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98. [3] Lutz T A.Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2023, 19(6): 350-360. [4] Wondmkun Y T.Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications[J]. Diabetes Metab Syndr Obes, 2020: 3611-3616. [5] Sebastian M J, Khan S K A, Pappachan J M, et al. Diabetes and cognitive function: An evidence-based current perspective[J]. World J Diabetes, 2023, 14(2): 92. [6] Biernacka A, Dobaczewski M, Frangogiannis N G.TGF-β signaling in fibrosis[J]. Growth Factors, 2011, 29(5): 196-202. [7] Ip S P, Poon M K T, Wu S S, et al. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity[J]. Planta Med, 1995, 61(5): 398-401. [8] Shu L, Zhang W, Huang C, et al.Troxerutin Protects Against Myocardial Ischemia/Reperfusion Injury Via Pi3k/Akt Pathway in Rats[J]. Cell Physiol Biochem, 2017, 44(5): 1939-1948. [9] Chiu P Y, Leung H Y, Ko K M.Schisandrin B Enhances Renal Mitochondrial Antioxidant Status, Functional and Structural Integrity, and Protects against Gentamicin-Induced Nephrotoxicity in Rats[J]. Biol Pharm Bull, 2008, 31(4): 602-605. [10] 巩俊英,韩娜娜,金芳,等.五味子乙素对缺氧缺血新生大鼠的脑保护作用及机制[J]. 贵州医科大学学报,2024,49(9):1335-1340. [11] Chiu P Y, Leung H Y, Poon M K T, et al. Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats[J]. Biogerontology, 2006, 7(4): 199-210. [12] Li C, Ji K, Kim E, et al.Schisandrin B mitigates oxidative damage in early porcine embryos exposed to Ochratoxin A via NRF2 pathway activation[J]. Anim Reprod Sci, 2025: 107889. [13] Ko K M, Lam B Y H. Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain[J]. Mol Cell Biochem, 2002, 238: 181-186. [14] 李先伟,杨解人. 五味子乙素抗H2O2诱导PC12细胞凋亡的机制[J]. 中国老年学杂志,2011,31(12):2244-2247. [15] 邹琼,严明敏,查运红,等. 五味子乙素保护神经细胞作用及其可能机制[J]. 医药导报,2013,32(8):1010-1014. [16] Biessels G J, Despa F.Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications[J]. Nat Rev Endocrinol, 2018, 14(10): 591-604. [17] Berbudi A, Khairani S, Tjahjadi A I.Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions[J]. Immunotargets Ther, 2025: 359-382. [18] Riederer P, Korczyn A D, Ali S S, et al.The diabetic brain and cognition[J]. J Neural Transm (Vienna), 2017, 124: 1431-1454. [19] Hölscher C.The role of GLP-1 in neuronal activity and neurodegeneration[J]. Vitam Horm, 2010, 84: 331-354. [20] Hansen H H, Barkholt P, Fabricius K, et al.The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy[J]. Brain Res, 2016, 1634: 158-170. [21] Shang J, Yan W, Cui X, et al.Schisandrin B, a potential GLP-1R agonist, exerts anti-diabetic effects by stimulating insulin secretion[J]. Mol Cell Endocrinol, 2023, 577: 112029.
|